Eton Pharmaceuticals (ETON) Current Leases (2019)

Eton Pharmaceuticals' (ETON) quarterly Current Leases came in at $133000.0 in Q4 2019.

Eton Pharmaceuticals (ETON) Current Leases (2019) Analysis & Trends

Eton Pharmaceuticals has disclosed Current Leases across 1 years of filings, most recently posting $133000.0 for Q4 2019.

  • Current Leases for Q4 2019 came in at $133000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was $133000.0 (changed N/A YoY), and the FY2019 annual result was $133000.0, changed N/A from the prior year.
  • Current Leases came in at $133000.0 for Q4 2019 at Eton Pharmaceuticals.
  • In the past five years, Current Leases ranged from a high of $133000.0 in Q4 2019 to a low of $133000.0 in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 23.81 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 7.58 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 5.58 Mn
10 Eton Pharmaceuticals 806.97 Mn 781.03 Mn 13.10 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 133,000.00